Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Pediatrics ; 94(4 Pt 1): 532-6, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7936866

ABSTRACT

Despite broad concerns about the welfare of children, most pediatric residents are not able to engage in child advocacy during their busy training years. Yet residency can provide an opportunity for young pediatricians to learn valuable advocacy skills by undertaking an independent project with an experienced mentor. We describe the University of Washington Pediatrics Residency Program's experience in training interested residents in child advocacy. Basic requirements are that advocacy projects must not interfere with clinical training, resident participation must be voluntary, and faculty with advocacy skills must be available to help guide the residents. Four resident projects are outlined and guidelines for instituting such programs are presented.


Subject(s)
Child Advocacy , Education, Medical, Graduate/organization & administration , Internship and Residency , Patient Advocacy , Pediatrics/education , Program Development , Child , Clinical Competence , Faculty, Medical , Humans , Mentors , Organizational Objectives , Societies, Medical , Washington
2.
Pediatr Infect Dis J ; 15(9): 777-82, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8878220

ABSTRACT

BACKGROUND: High dose vitamin A therapy is effective in reducing morbidity and mortality associated with measles infection. Children with acute respiratory syncytial virus (RSV) infection have low serum vitamin A concentrations. METHODS: We performed a multicenter, randomized, placebo-controlled trial of high dose vitamin A therapy among 239 children 1 month to 6 years of age to determine whether high dose vitamin A therapy would reduce morbidity associated with RSV infection. RESULTS: There were no differences between the vitamin A and placebo recipients for most clinical outcomes; however, vitamin A recipients had-longer hospital stays than placebo recipients (5.0 days vs. 4.4 days, P = 0.01) after enrollment. This effect was significant for children who were older than 1 year (who also had received the highest doses of vitamin A), particularly among those at low risk for complications of RSV infection and those enrolled during the second study season. Serum retinol levels at enrollment were inversely correlated with severity of illness. CONCLUSIONS: We found no evidence of a beneficial effect of vitamin A for the treatment of RSV infection in children in the United States. There may be groups of children for which vitamin A has an adverse effect, resulting in longer hospital stays.


Subject(s)
Respiratory Syncytial Virus Infections/drug therapy , Vitamin A/therapeutic use , Child , Child, Preschool , Double-Blind Method , Female , Humans , Infant , Male , Vitamin A/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL